- Home
- KBH vs AXSM Comparison
KBH vs AXSM Comparison
Compare KBH & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KBH
- AXSM
- Stock Information
- Founded
- KBH 1957
- AXSM 2012
- Country
- KBH United States
- AXSM United States
- Employees
- KBH N/A
- AXSM N/A
- Industry
- KBH Homebuilding
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- KBH Consumer Discretionary
- AXSM Health Care
- Exchange
- KBH Nasdaq
- AXSM Nasdaq
- Market Cap
- KBH 4.6B
- AXSM 5.1B
- IPO Year
- KBH 1987
- AXSM 2015
- Fundamental
- Price
- KBH $65.02
- AXSM $116.62
- Analyst Decision
- KBH Hold
- AXSM Strong Buy
- Analyst Count
- KBH 13
- AXSM 17
- Target Price
- KBH $67.88
- AXSM $175.76
- AVG Volume (30 Days)
- KBH 1.2M
- AXSM 576.1K
- Earning Date
- KBH 09-24-2025
- AXSM 11-11-2025
- Dividend Yield
- KBH 1.53%
- AXSM N/A
- EPS Growth
- KBH 0.49
- AXSM N/A
- EPS
- KBH 7.59
- AXSM N/A
- Revenue
- KBH $6,673,869,000.00
- AXSM $495,033,000.00
- Revenue This Year
- KBH N/A
- AXSM $63.78
- Revenue Next Year
- KBH N/A
- AXSM $55.74
- P/E Ratio
- KBH $8.59
- AXSM N/A
- Revenue Growth
- KBH 3.65
- AXSM 69.83
- 52 Week Low
- KBH $48.90
- AXSM $75.56
- 52 Week High
- KBH $89.70
- AXSM $139.13
- Technical
- Relative Strength Index (RSI)
- KBH 55.09
- AXSM 48.36
- Support Level
- KBH $64.27
- AXSM $112.90
- Resistance Level
- KBH $67.52
- AXSM $130.00
- Average True Range (ATR)
- KBH 1.73
- AXSM 3.70
- MACD
- KBH -0.29
- AXSM -1.47
- Stochastic Oscillator
- KBH 42.61
- AXSM 21.75
About KBH KB Home
KB Home is an American construction company that focuses on residential construction in the United States. The company builds single-family homes and communities across different geographical segments which include the West Coast which also derives the majority of the revenue, Southwest, Central, and Southeast. The company operates in several markets and focuses on first-time and move-up homebuyers. It also invests in land acquisition and development to support future building activities and is also engaged in financial services operations which includes providing mortgage banking services through its joint venture with a third party.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.